
Dr. Sergey Macheret Publishes New Blog on Microwave Discharge Plasmas in High-Speed Flight
Dr. Sergey Macheret, a leading expert in plasma science and aerospace engineering, has published a new personal blog article titled 'Microwave Discharge Plasmas: A Re-Emerging Tool for Aerodynamic Control and Propulsion'. The article explores emerging strategies to enhance aerodynamic control and propulsion efficiency in hypersonic and near-space environments using microwave-generated plasma.
'Microwave discharges offer a unique combination of non-intrusiveness, volumetric energy deposition, and adaptability to complex flight environments,' says Dr. Macheret. 'But operating them under high-speed, low-pressure conditions introduces new layers of complexity we're only beginning to fully understand.'
Microwave discharges are being re-evaluated as a viable method to generate plasma for aircraft and spacecraft that travel at speeds exceeding Mach 8 and altitudes above 30 kilometers. These conditions produce thermochemically nonequilibrium flows, where conventional assumptions about plasma behavior no longer apply. Dr. Macheret's blog details how these discharges behave differently due to factors like non-Maxwellian electron energy distributions and long electron energy relaxation lengths.
The blog also addresses key application areas:
Flow Control: Pulsed microwave discharges could delay boundary layer separation or create virtual control surfaces.
Propulsion Enhancement: In scramjets, microwave fields can aid flame ignition and accelerate flame propagation—even without full plasma breakdown.
'By heating the flame front selectively, even sub-breakdown microwave fields can significantly enhance combustion,' he explains.
Dr. Macheret's work has helped shape modern plasma-assisted flight research. He has held research and leadership roles at institutions including Princeton University, Lockheed Martin Skunk Works, and Purdue University. He currently serves as Co-Founder and CTO of US Plasma Engineering LLC.
To read the full article, visit https://sergeymacheret.com.
Contact:
info@drsergeymacheret.com
Media Contact
Contact Person: Sergey Macheret
Email: Send Email
Country: United States
Website: https://sergeymacheret.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
9 hours ago
- Globe and Mail
Oklo Stock: Up 900%, Can It Still Make You Rich?
Oklo (NYSE: OKLO) stock is up 900% -- without a single reactor running. In this video, I'll explore the explosive rise of this nuclear innovator, why it's capturing AI-fueled investor interest, and whether this speculation is genius -- or insanity. *Stock prices used were the market prices of July 5, 2025. The video was published on July 11, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Should you invest $1,000 in Oklo right now? Before you buy stock in Oklo, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,432!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,005,854!* Now, it's worth noting Stock Advisor 's total average return is1,049% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Rick Orford has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.


Globe and Mail
10 hours ago
- Globe and Mail
Dr. Sergey Macheret Publishes New Blog on Microwave Discharge Plasmas in High-Speed Flight
The veteran physicist and aerospace engineer shares insights into the challenges and breakthroughs in microwave plasma applications for next-generation flight systems. Dr. Sergey Macheret, a leading expert in plasma science and aerospace engineering, has published a new personal blog article titled 'Microwave Discharge Plasmas: A Re-Emerging Tool for Aerodynamic Control and Propulsion'. The article explores emerging strategies to enhance aerodynamic control and propulsion efficiency in hypersonic and near-space environments using microwave-generated plasma. 'Microwave discharges offer a unique combination of non-intrusiveness, volumetric energy deposition, and adaptability to complex flight environments,' says Dr. Macheret. 'But operating them under high-speed, low-pressure conditions introduces new layers of complexity we're only beginning to fully understand.' Microwave discharges are being re-evaluated as a viable method to generate plasma for aircraft and spacecraft that travel at speeds exceeding Mach 8 and altitudes above 30 kilometers. These conditions produce thermochemically nonequilibrium flows, where conventional assumptions about plasma behavior no longer apply. Dr. Macheret's blog details how these discharges behave differently due to factors like non-Maxwellian electron energy distributions and long electron energy relaxation lengths. The blog also addresses key application areas: Flow Control: Pulsed microwave discharges could delay boundary layer separation or create virtual control surfaces. Propulsion Enhancement: In scramjets, microwave fields can aid flame ignition and accelerate flame propagation—even without full plasma breakdown. 'By heating the flame front selectively, even sub-breakdown microwave fields can significantly enhance combustion,' he explains. Dr. Macheret's work has helped shape modern plasma-assisted flight research. He has held research and leadership roles at institutions including Princeton University, Lockheed Martin Skunk Works, and Purdue University. He currently serves as Co-Founder and CTO of US Plasma Engineering LLC. To read the full article, visit Contact: info@ Media Contact Contact Person: Sergey Macheret Email: Send Email Country: United States Website:


Globe and Mail
11 hours ago
- Globe and Mail
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation ('Quanterix' or the 'Company') (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that on July 8, 2025, the Company approved inducement grants of restricted stock units ('RSUs') representing 267,269 shares of Quanterix common stock to twenty employees newly-hired in connection with the acquisition of Akoya Biosciences, Inc. The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with the Company. The RSUs vest in full on the one year anniversary of the grant date, subject to the applicable individual's continued employment with the Company or one of its subsidiaries through the vesting date. About Quanterix Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa ® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company ®, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics.